**7. References**


Alzheimer's Disease and Are Neurotoxic When Oxidized Ex Vivo. *Lipids,* Vol. 34, No. 12, (Dec 1999), pp. 1273-1280.


Human Superoxide Dismutase Inhibits Oxidation of Low-Density Lipoprotein by Endothelial Cells. *Circ. Res.,* Vol. 82, No. 12, pp. 1289-1297, 1524-4571.

Furuhata, A., Ishii, T., Kumazawa, S., Yamada, T., Nakayama, T. & Uchida, K. (2003). N(epsilon)-(3-methylpyridinium)lysine, a major antigenic adduct generated in acrolein-modified protein. *J. Biol. Chem.*, Vol. 278, No. 49, (Dec 2003), pp. 48658- 48665.

404 Lipoproteins – Role in Health and Diseases

12, (Dec 1999), pp. 1273-1280.

No. 4, (1985), pp. 309-380.

2, (Oct 2000), pp. 87-90.

1, (Jan 1999), pp. 1-28.

No. 1, pp. 81-128.

*(USA),* Vol. 101, No. 35, (Aug 2004), pp. 13032-13037.

*New Engl. J. Med.*, Vol. 353, No. 1, (Jul 2005), pp. 9-11.

*Free Rad. Biol. Med.*, Vol. 12, No. 3, (1992), pp. 193-203.

*Invest.*, Vol. 94, No. 1, (Jul 1994), pp. 437-444.

*Biochim. Biophys. Acta*, Vol. 1703, No. 2, (Jan 2005), pp. 149-156.

disease. *Biochim. Biophys. Acta*, Vol. 1801, No. 8, (Aug 2010), pp. 924-929.

deficient mice. *J. Clin. Invest.*, Vol. 103, No. 11, (Jun 1999), pp. 1597-1604.

Vol. 39, No. 8, (Aug 1998), pp. 1594-1600.

Alzheimer's Disease and Are Neurotoxic When Oxidized Ex Vivo. *Lipids,* Vol. 34, No.

Beauchamp, R. O., Jr., Andjelkovich, D. A., Kligerman, A. D., Morgan, K. T. & Heck, H. D. (1985). A critical review of the literature on acrolein toxicity. *Crit. Rev. Toxicol.*, Vol. 14,

Bergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., Geary, R. L., Oram, J. F. & Heinecke, J. W. (2004). The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. *Proc. Natl. Acad. Sci.* 

Berliner, J. A. & Watson, A. D. (2005). A Role for Oxidized Phospholipids in Atherosclerosis.

Björkhem, I., Lütjohann, D., Diczfalusy, U., Ståhle, L., Ahlborg, G. & Wahren, J. (1998). Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. *J. Lipid Res.*,

Bretillon, L., Sidén, A., Wahlund, L. O., Lütjohann, D., Minthon, L., Crisby, M., Hillert, J., Groth, C. G., Diczfalusy, U. & Björkhem, I. (2000). Plasma levels of 24Shydroxycholesterol in patients with neurological diseases. *Neurosci. Lett.*, Vol. 293, No.

Bradamante, S., Barenghi, L., Giudici, G. A. & Vergani, C. (1992). Free radicals promote modifications in plasma high-density lipoprotein: nuclear magnetic resonance analysis.

Brown, A. J. & Jessup, W. (1999). Oxysterols and atherosclerosis. *Atherosclerosis*, Vol. 142, No.

Butterfield, D. A. & Boyd-Kimball, D. (2005). The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.

Butterfield, D. A., Bader Lange, M. L. & Sultana, R. (2010). Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's

Cyrus, T., Witztum, J. L., Rader, D. J., Tangirala, R., Fazio, S., Linton, M. F. & Funk, C. D. (1999). Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-

Daugherty, A., Dunn, J. L., Rateri, D. L. & Heinecke, J. W. (1994). Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. *J. Clin.* 

Esterbauer, H., Schaur, R. & Zollner, H. (1991). Chemistry and Biochemistry of 4 hydroxynonenal, Malonaldehyde and Related Aldehydes. *Free Rad. Biol. Med.,* Vol. 11,

Fang, X., Weintraub, N. L., Rios, C. D., Chappell, D. A., Zwacka, R. M., Engelhardt, J. F., Oberley, L. W., Yan, T., Heistad, D. D. & Spector, A.A. (1998). Overexpression of


Palinski, W., Ylä-Herttuala, S., Rosenfeld, M. E., Butler, S. W., Socher, S. A., Parthasarathy, S., Curtiss, L. K., Witztum, J. L. (1990) Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein, *Arteriosclerosis*, Vol. 10, No 10 (3) (May-Jun 1990), 325-335.

406 Lipoproteins – Role in Health and Diseases

No. 2, (Mar-Apr 2001), pp. 187-194.

Vol. 145, No 3, (Apr 29), pp. 341-355.

*(USA)*, Vol. 93, No. 18, (Sept 1996), pp. 9799-9804.

pp. 39-75.

38.

1606.

202-210.

1834.

pp. 481-488.

Laukkanen, M. O., Lehtolainen, P., Turunen, P., Aittomäki, S., Oikari, P., Marklund, S. L., Ylä-Herttuala, S. (2000). Rabbit extracellular superoxide dismutase: expression and

Leoni, V. & Caccia, C. (2011). Oxysterols as Biomarkers in Neurodegenerative Diseases.

Levitan, I., Volkov, S. & Subbaiah, P. V. (2010). Oxidized LDL: diversity, patterns of recognition, and pathophysiology. *Antioxid. & Redox Signaling*, Vol. 13, No. 1, (Jul 2010),

Lovell, M. A., Xie, C. & Markesbery, W. R. (2001). Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. *Neurobiol. Aging*, Vol. 22,

Lütjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Sidén, A., Diczfalusy, U. & Björkhem, I. (1996). Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. *Proc. Natl. Acad. Sci.* 

Maritim, A. C., Sanders, R. A., & Watkins, J. B. (2003). Diabetes, Oxidative Stress, and Antioxidants: A Review. *J. Biochem. Mol. Toxicol.,* Vol. 17, No. 1, (Feb 2003), pp. 24-

McCall, M. R., Tang, J. Y., Bielicki, J. K. & Forte, T. M. (1995). Inhibition of Lecithin-Cholesterol Acyltransferase and Modification of HDL Apolipoproteins by Aldehydes. *Arterioscl. Thromb. Vasc. Biol.,* Vol. 15, No. 10, (Oct 1995), pp. 1599-

Meyer, J. & Schmitt, M.E. (2000). A Central Role for the Endothelial NADPH Oxidase in

Montine, T. J., Huang, D. Y., Valentine, W. M., Amarnath, V., Saunders, A., Weisgraber, K. H., Graham, D. G. & Strittmatter, W. J. (1996). Crosslinking of apolipoprotein E by products of lipid peroxidation. *J. Neuropathol. Exp. Neurol.*, Vol. 55, No. 2, (Feb 1996), pp.

Moore, K. J. & Tabas, I. (2011) Macrophages in the pathogenesis of atherosclerosis. *Cell*, 2011

Morel, D. W. & Chisolm, G. M. (1989). Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. *J. Lipid Res.*, Vol. 30, No. 12, (Dec 1989), pp. 1827-

Navab, M., Berliner, J. A., Subbanagounder, G., Hama, S., Lusis, A. J., Castellani, L. W., Reddy, S., Shih, D., Shi, W., Watson, A. D., Van Lenten, B. J., Vora, D. & Fogelman, A. M. (2001). HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. *Arterioscl. Thromb. Vasc. Biol.,* Vol. 21, No. 4, (Apr 2001),

Noor, R., Mittal, S. & Iqbal, J. (2002). Superoxide dismutase--applications and relevance to human diseases. *Medical Science Monitor: International Medical Journal of Experimental and* 

Olkkonen, V. M. & Lehto, M. (2004). Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. *Ann. Med.*, Vol. 36, No. 8, (2004), pp. 562-572.

Atherosclerosis. *FEBS Lett.,* Vol. 472, No. 1, (Apr 2000), pp. 1-4.

*Clinical Research*, Vol. 8, No. 9, (Sep 2002), pp. 210-215.

effect on LDL oxidation. *Gene*, Vol. 254, No. 1-2, (Aug 2000), pp. 173-179.

*Chem. Phys. Lipids*, Vol. 164, No. 6, (Sept 2011), pp. 515-524.

